Nuveen Asset Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.4M | Sell |
798,482
-24,003
| -3% | -$42K | ﹤0.01% | 2540 |
|
|
2024
Q3 | $1.59M | Buy |
822,485
+39,333
| +5% | +$75.9K | ﹤0.01% | 2534 |
|
|
2024
Q2 | $1.39M | Buy |
+783,152
| New | +$1.39M | ﹤0.01% | 2564 |
|
|
2022
Q2 | – | Sell |
-1,599,180
| Closed | -$5.87M | – | 3332 |
|
|
2022
Q1 | $5.87M | Sell |
1,599,180
-355,906
| -18% | -$1.31M | ﹤0.01% | 1971 |
|
|
2021
Q4 | $7.66M | Buy |
1,955,086
+23,251
| +1% | +$91.1K | ﹤0.01% | 1847 |
|
|
2021
Q3 | $13.4M | Buy |
1,931,835
+292,032
| +18% | +$2.03M | ﹤0.01% | 1573 |
|
|
2021
Q2 | $10.1M | Buy |
1,639,803
+384,905
| +31% | +$2.37M | ﹤0.01% | 1856 |
|
|
2021
Q1 | $5.67M | Buy |
1,254,898
+57,419
| +5% | +$260K | ﹤0.01% | 2113 |
|
|
2020
Q4 | $7.19M | Buy |
1,197,479
+163,618
| +16% | +$982K | ﹤0.01% | 1892 |
|
|
2020
Q3 | $7.68M | Sell |
1,033,861
-83,293
| -7% | -$619K | ﹤0.01% | 1674 |
|
|
2020
Q2 | $4.48M | Buy |
1,117,154
+48,584
| +5% | +$195K | ﹤0.01% | 1960 |
|
|
2020
Q1 | $2.71M | Sell |
1,068,570
-928
| -0.1% | -$2.36K | ﹤0.01% | 2037 |
|
|
2019
Q4 | $3.72M | Sell |
1,069,498
-120,720
| -10% | -$420K | ﹤0.01% | 2142 |
|
|
2019
Q3 | $5.51M | Buy |
1,190,218
+63,977
| +6% | +$296K | ﹤0.01% | 1901 |
|
|
2019
Q2 | $13.9M | Buy |
+1,126,241
| New | +$13.9M | 0.01% | 1395 |
|